Go to Client Portal

MDR Summit Tokyo



Date(s) - May 16, 2023
10:30 AM - 04:00 PM JST


Nihonbashi Life Science Building
2 Chome-3-11 Nihonbashihoncho, Chuo,
Tokyo, 103-0023


MDR Summit

Date: 16 May 2023
Location: Nihonbashi Life Science Building
Price: $200 USD

NAMSA is delighted to be back in Tokyo for another MDR summit, led by one of our foremost experts on MDR: Adrian Keene, BSc (HONS); Associate Vice President of Global Biological Safety & Validation and EMEA Consulting Services (for more information, please review the Speaker information below).

This half-day summit provides practical solutions for navigating the European Union Medical Device Regulation (EU MDR). Designed for professionals in the medical device industry, this course will equip you with the knowledge and skills you need to successfully implement the EU MDR requirements in your organization.

Please review the Agenda below for further information.

Attendees will have the opportunity to ask questions during the interactive Q&A session, as well as extensive time available in the afternoon for one to one discussion sessions with our expert.

If you would like to schedule a more formal consulting session with Adrian, please contact your Account Manager.


MDR Summit

所在地 日本橋ライフサイエンスビルディング

MDR Summit Information (PDF)


この半日サミットでは、欧州連合医療機器規制(EU MDR)を円滑に進めるための実践的な解決策を提供します。医療機器業界のプロフェッショナル向けに設計されたこのコースは、EU MDRの要件を組織で成功裏に実施するために必要な知識とスキルを身につけることができます。




NOTE: Our security measures require that your credit card billing address match your profile address.

*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

Register Here

MDR Summit Tokyo

Login to Continue

You must be logged in to register for an event. Don't have an account? Please register here.

10:00 – 10:30


10:30 – 12:00

Part 1
  • Update and implications of the extension of the MDR transition period
  • Operational considerations to ensure you can transition your EU device portfolio to the MDR
  • (incl Q&A)

12:00 – 13:00


13:00 – 14:30

Part 2
  • Learnings from deficiencies and feedback observed from notified bodies
  • Practical approaches to post market surveillance (PMS) and post market clinical follow up (PMCF) requirements
  • (incl Q&A)

14:30 – 16:00


Adrian Keene will be available for one to one discussions


Adrian Keene, BSc (Hons)

Associate Vice President of Global Biological Safety & Validation and EMEA Consulting Services

With 26 years of experience in the medical device industry, Adrian’s knowledge of new product development combined with EU regulatory requirements enables him to provide a balanced interpretation of the needs and expectations of both competent authorities and manufacturers. He works with a broad range of devices including drug-device combination products.

Prior to working at NAMSA, Adrian was Head of Notified Body for the UK Notified Body SGS. Before working with the notified body, he was Global Clinical Affairs and Regulatory Manager for Medical Devices, with responsibility for conformity assessment activities of high risk (class III) devices under the Medical Device Directive (MDD).

He attended the School of Pharmacy at the University of London following and conducted postgraduate research in “Retinoid-Induced Skeletal Toxicity.” He also holds a diploma in “Managing Medical Product Innovation” from the Scandinavian International Management Institute.